ClinicalTrials.gov
ClinicalTrials.gov Menu

Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (UNIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01196884
Recruitment Status : Unknown
Verified September 2010 by Azienda Sanitaria-Universitaria Integrata di Udine.
Recruitment status was:  Recruiting
First Posted : September 9, 2010
Last Update Posted : March 20, 2018
Sponsor:
Information provided by:
Azienda Sanitaria-Universitaria Integrata di Udine

Brief Summary:

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.


Condition or disease
Thrombocytopenia

Study Type : Observational
Estimated Enrollment : 190 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT
Study Start Date : September 2010


Group/Cohort
Asymptomatic ITP patients
ITP patients treated with Rituximab
ITP patients treated with steroids




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Primary care clinic
Criteria

Inclusion Criteria:

  • Adult patients with primary ITP

Exclusion Criteria:

  • Secondary ITP

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01196884


Contacts
Contact: Francesco Zaja, MD +39 0432 559604 zaja.francesco@aoud.sanita.fvg.it

Locations
Italy
Istituto di Ematologia L. & A. Seragnoli Recruiting
Bologna, Italy, 40100
Contact: Nicola Vianelli, MD         
Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco Not yet recruiting
Cagliari, Italy, 09100
Contact: Emilio Usala, MD         
UF Ematologia, Policlinico di Careggi Not yet recruiting
Firenze, Italy
Contact: Antonella Gozzini, MD         
U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico Not yet recruiting
Milano, Italy, 20122
Contact: Wilma Barcellini, MD         
Department of Oncology/Haematology, Niguarda Ca'Granda Hospital Recruiting
Milano, Italy
Contact: Silvia Cantoni, MD         
Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro Recruiting
Novara, Italy, 28100
Contact: Gianluca Gaidano, Prof.         
Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro" Active, not recruiting
Novara, Italy, 28100
Department of Medical and Surgical Sciences, University of Padova Not yet recruiting
Padova, Italy, 35100
Contact: Fabrizio Fabris, Prof.         
Oncology-Hematology Department, "S. Maria delle Croci" Hospital Not yet recruiting
Ravenna, Italy, 48121
Contact: Alfonso Zaccaria, MD         
Institute of Hematology, Catholic University, Not yet recruiting
Roma, Italy, 00168
Contact: Valerio De Stefano, MD         
Ematologia, Ospedale Ca' Foncello Not yet recruiting
Treviso, Italy, 31100
Contact: Filippo Gherlinzoni, MD         
Clinica Ematologica AOUD S. Maria Misericordia Recruiting
Udine, Italy, 33100
Contact: Francesco Zaja, MD    +39 0432559604    zaja.francesco@aoud.sanita.fvg.it   
Principal Investigator: Francesco Zaja, MD         
Ematologia, San Bortolo Hospital Not yet recruiting
Vicenza, Italy, 36100
Contact: Francesco Rodeghiero, Prof.         
Sponsors and Collaborators
Azienda Sanitaria-Universitaria Integrata di Udine

Responsible Party: Francesco Zaja, Clinica Ematologica, Azienda Ospedaliero Universitaria S. Maria Misericordia di Udine
ClinicalTrials.gov Identifier: NCT01196884     History of Changes
Other Study ID Numbers: UNIT
First Posted: September 9, 2010    Key Record Dates
Last Update Posted: March 20, 2018
Last Verified: September 2010

Keywords provided by Azienda Sanitaria-Universitaria Integrata di Udine:
Patients with primary Immune Thrombocytopenia (ITP)

Additional relevant MeSH terms:
Thrombocytopenia
Purpura, Thrombocytopenic, Idiopathic
Blood Platelet Disorders
Hematologic Diseases
Purpura, Thrombocytopenic
Purpura
Blood Coagulation Disorders
Thrombotic Microangiopathies
Hemorrhagic Disorders
Autoimmune Diseases
Immune System Diseases
Hemorrhage
Pathologic Processes
Skin Manifestations
Signs and Symptoms